Market Outlook: - Nifty managed to claw-back some lost ground, helped in good measure by western cues to cease the day with gains. - Overnight statements from Fed. Chair has soothen-up some nerves which in-turn will help local bourses to trade with gains. - We believe markets are in for some consolidation, which could provide some good investment opportunities. - We believe amongst others, PSU banking pack offers an interesting bet, which would be amongst major beneficiaries of falling rates (helped by falling commodity prices). News: - Zee Entertainment (Z IN) to replace United Spirits (UNSP IN) in Nifty w.e.f. tomorrow. - As per media reports, Oil minister is expected to discuss report of gas pricing submitted by panel of secretaries today and thereafter forward its final recommendation to Cabinet Committee on Economic Affairs (CCEA) for approval. - IPCA IN: Health Canada has asked Co. to voluntarily stop shipment of products to Canada based on a review of a recent GMP inspection report by US FDA where they identified falsification & manipulation of data issues at Co. - SUNP IN: Co. has entered into agreement with Merck Sharpe & Dome (MSD) for an exclusive worldwide licensing of its antibody candidate - Tildrakizumab making upfront payment of $80mn.. Investigational candidate is currently under Phase III trials for treatment of plaque psoriasis. Under the deal, Merck will receive upfront payment and is also entitled to receive milestone payments & royalties as drug receives various approvals & milestones. - RBXY IN: Co. has been approached by US federal authorities seeking details on how it reports pricing data for some products eligible for reimbursement under the Medicaid program. - Natco Pharma (NTCPH IN) & Orchid Chemicals and Pharma (OCP IN) have received adverse observation report, commonly known as Form 483, after inspections conducted at their units earlier this year by USFDA. - CAIR IN: Co. has made 3-new oil discoveries in Rajasthan block, taking total number of finds in block to 36. - APHS IN: Co signed deal to acquire drug retail chain of Hyderabad-based Hetero Med Solutions Ltd for Rs. 1.46bn. bit.ly/1rcRBrQ
Posted on: Thu, 18 Sep 2014 03:55:21 +0000
Trending Topics
Recently Viewed Topics
© 2015